ASX Filings

Opthea Completes Enrollment in First Trial of Sozinibercept

February 15, 2024

Opthea Strengthens Team with Key Clinical & Regulatory Hires

February 2, 2024

Opthea to Receive US$35M Commitment and Additional US$50M

December 27, 2023

Change of Director's Interest Notice - JL

December 21, 2023

Change of Director's Interest Notice - LG

December 21, 2023

Change of Director's Interest Notice - AT

December 21, 2023

Change of Director's Interest Notice - MB

December 21, 2023

Notification regarding unquoted securities - OPT

December 21, 2023

Notification regarding unquoted securities - OPT

December 21, 2023

Notification regarding unquoted securities - OPT

December 21, 2023